In an attempt to test our second aim reclaiming whether obesity is a cofounder for apelin serum levels association with CHC disease progression, we analyzed apelin levels in the obese (36 patients) versus lean (37 patients). The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.